Davita Inc vs Texas Instruments Incorporated — how do they compare? Davita Inc trades at $232.01 (market cap $15.12B), while Texas Instruments Incorporated trades at $309.4 (market cap $271.73B). The key difference: Texas Instruments Incorporated is far larger — about 18× Davita Inc's market cap, and Texas Instruments Incorporated pays a 1.9% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | TXN | |
|---|---|---|
Market Cap | $15.12B | $271.73B |
Sector | Health | Technology |
52-Week High | $235.71 | $332.35 |
52-Week Low | $103.87 | $153.33 |
Enterprise Value | $27.67B | $280.67B |
Dividend Yield | — | 1.9% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Texas Instruments (TXN) trades at $305.55, down 1.91% with a bearish technical signal. The company shows improving fundamentals with Q1 2026 earnings beat ($1.68 vs $1.36 expected) and revenue growth to $17.68B in 2025. Recent CFO transition to Julie Knecht and strong AI-related demand from data centers provide positive catalysts. Valuation remains elevated with P/E of 51.04 and P/S of 14.78, while maintaining strong profitability with 29.11% net margin and 32.18% ROE.
TXN presents a mixed outlook with solid fundamentals offset by premium valuation. The stock offers exposure to growing AI infrastructure demand and operational improvements, but faces risks from competitive pressures and debt levels. Analyst consensus leans bullish with $317.20 price target, though technical indicators suggest near-term caution. The current price near pivot point resistance requires monitoring for breakout confirmation.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →